Delivery Order SPE2DB22D1017-SPE2DB25FG1FU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $10,662.57 and is scheduled for completion by October 15, 2025. The award was made on a competitive basis without any set-aside designation, and the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57 under a firm fixed price contract. This delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX and valued at $999,999,999.00 through December 2026), represents a competitive, non-set-aside award with an ultimate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, was awarded a delivery order valued at $10,662.57 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by May 12, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages) valued at $10,662.57 under a Firm Fixed Price contract type. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract value of $21,325.14. This non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has established...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price contract, with an ultimate completion date of July 10, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG1FUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Tagrisso 80 mg tablets (30-count packaging) with a ceiling value of $10,662.57 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive portfolio of Defense Logistics Agency contracts demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX contract represents a strategic partnership enabling AmerisourceBergen to supply pharmaceutical products globally to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 4/29/25 |